UC's tobacco-free campaign receives national recognition
American Cancer Society recognizes UC with the Guardians of the Campus Environment Award
The University of Cincinnati has received the Guardians of the Campus Environment Award from the American Cancer Society in recognition of its tobacco-free campus campaign.
The campaign, coordinated by staff from the Student Wellness Center, Be Well UC, UC Blue Ash and UC Clermont, relied on environmental scanning to examine tobacco use in various locations around UC’s campuses.
Tobacco use was recorded to identify campus “hot spots” where tobacco use is high. The groups developed an interactive map of high-use locations to help inform future programming efforts. The map will be used to determine where additional signage and awareness events should occur.
UC staff hosted public educational events as part of its tobacco-free campus campaign. Photo/Sarah Blanton/UC
“The Student Wellness Center is really excited to receive the award in recognition of the hard work we've been putting into the environmental scan and map to track hot spots and compliance of the tobacco-free policy on campus," said Sarah Blanton, who coordinates educational programs about alcohol, tobacco and drugs at the Student Wellness Center. "We plan to continue the environmental scans each semester to stay up to date about where hot spots are located on campus and how we can increase compliance in those areas with awareness programming.”
UC’s tobacco-free policy went into effect on May 1, 2017. Tobacco products including, but not limited to, cigarettes, electronic cigarettes, vaporizing devices, cigars and cigarillos, hookah smoked products, pipes, oral tobacco (e.g., spit and spitless, smokeless, chew or snuff), nasal tobacco (e.g., snus) are prohibited. The policy also includes any products that are intended to mimic tobacco products or contain tobacco flavoring and the smoking of any other substance which delivers nicotine.
UC students, faculty, staff and visitors can support efforts by reporting tobacco use via email or the Tobacco Free UC website.
Related Stories
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.
Study: Additional radiation for liver cancer does not increase toxicity
March 10, 2026
New research led by University of Cincinnati Cancer Center researchers published in the American Journal of Clinical Oncology found external beam radiation therapy (EBRT) is safe to administer to patients with liver cancer even after they undergo a targeted internal radiation therapy called Y90.
Is uACR the key to cardiovascular and kidney disease prevention?
March 8, 2026
As a precision biomarker, the urinary albumin-to-creatinine ratio (uACR) can guide physicians toward personalized, patient-centered prevention and treatment of both cardiovascular disease (CVD) and chronic kidney disease (CKD), according to new data published in the Journal of Internal Medicine.